Atria Investments’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.48M | Sell |
41,688
-2,859
| -6% | -$307K | 0.05% | 413 |
|
2025
Q1 | $4.49M | Buy |
44,547
+18
| +0% | +$1.82K | 0.06% | 405 |
|
2024
Q4 | $3.98M | Sell |
44,529
-604
| -1% | -$53.9K | 0.05% | 426 |
|
2024
Q3 | $3.78M | Sell |
45,133
-2,823
| -6% | -$237K | 0.05% | 441 |
|
2024
Q2 | $3.69M | Buy |
47,956
+3,202
| +7% | +$247K | 0.05% | 431 |
|
2024
Q1 | $3.07M | Buy |
44,754
+4,944
| +12% | +$339K | 0.04% | 504 |
|
2023
Q4 | $2.3M | Sell |
39,810
-7,600
| -16% | -$439K | 0.04% | 545 |
|
2023
Q3 | $2.5M | Buy |
47,410
+10,926
| +30% | +$577K | 0.04% | 485 |
|
2023
Q2 | $1.97M | Buy |
36,484
+5,587
| +18% | +$302K | 0.04% | 561 |
|
2023
Q1 | $1.55M | Buy |
30,897
+3,802
| +14% | +$190K | 0.03% | 639 |
|
2022
Q4 | $1.25M | Buy |
+27,095
| New | +$1.25M | 0.03% | 673 |
|
2022
Q3 | – | Sell |
-27,107
| Closed | -$1.01M | – | 741 |
|
2022
Q2 | $1.01M | Sell |
27,107
-1,190
| -4% | -$44.3K | 0.02% | 745 |
|
2022
Q1 | $1.25M | Sell |
28,297
-5,030
| -15% | -$223K | 0.02% | 752 |
|
2021
Q4 | $1.42M | Sell |
33,327
-6,036
| -15% | -$256K | 0.03% | 693 |
|
2021
Q3 | $1.71M | Buy |
39,363
+7,697
| +24% | +$334K | 0.03% | 589 |
|
2021
Q2 | $1.35M | Buy |
+31,666
| New | +$1.35M | 0.03% | 656 |
|
2020
Q1 | – | Sell |
-12,031
| Closed | -$544K | – | 628 |
|
2019
Q4 | $544K | Buy |
+12,031
| New | +$544K | 0.01% | 756 |
|
2019
Q3 | – | Sell |
-4,953
| Closed | -$209K | – | 871 |
|
2019
Q2 | $209K | Buy |
+4,953
| New | +$209K | 0.01% | 893 |
|
2018
Q3 | – | Sell |
-6,201
| Closed | -$203K | – | 978 |
|
2018
Q2 | $203K | Buy |
+6,201
| New | +$203K | 0.01% | 911 |
|